304 related articles for article (PubMed ID: 24622264)
1. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
Kramer CK; Zinman B; Retnakaran R
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):28-34. PubMed ID: 24622264
[TBL] [Abstract][Full Text] [Related]
2. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
3. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY
Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
Weng J; Li Y; Xu W; Shi L; Zhang Q; Zhu D; Hu Y; Zhou Z; Yan X; Tian H; Ran X; Luo Z; Xian J; Yan L; Li F; Zeng L; Chen Y; Yang L; Yan S; Liu J; Li M; Fu Z; Cheng H
Lancet; 2008 May; 371(9626):1753-60. PubMed ID: 18502299
[TBL] [Abstract][Full Text] [Related]
5. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
Liu L; Ke W; Wan X; Zhang P; Cao X; Deng W; Li Y
Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
[TBL] [Abstract][Full Text] [Related]
6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
7. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.
Liu J; Liu J; Fang D; Liu L; Huang Z; Wan X; Cao X; Li Y
Endocr J; 2013; 60(6):725-32. PubMed ID: 23428844
[TBL] [Abstract][Full Text] [Related]
8. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Liu L; Wan X; Liu J; Huang Z; Cao X; Li Y
Diabetes Technol Ther; 2012 Sep; 14(9):756-61. PubMed ID: 22731793
[TBL] [Abstract][Full Text] [Related]
9. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
Li Y; Xu W; Liao Z; Yao B; Chen X; Huang Z; Hu G; Weng J
Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
[TBL] [Abstract][Full Text] [Related]
10. Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission.
Zhang B; Chen YY; Yang ZJ; Wang X; Li GW
J Int Med Res; 2016 Dec; 44(6):1543-1550. PubMed ID: 27834301
[TBL] [Abstract][Full Text] [Related]
11. Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes.
Kramer CK; Choi H; Zinman B; Retnakaran R
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1398-407. PubMed ID: 24129396
[TBL] [Abstract][Full Text] [Related]
12. Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment.
Chen A; Huang Z; Wan X; Deng W; Wu J; Li L; Cai Q; Xiao H; Li Y
Diabetes Care; 2012 Mar; 35(3):474-81. PubMed ID: 22228747
[TBL] [Abstract][Full Text] [Related]
13. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
Li YB; Zeng LY; Shi LX; Zhu DL; Zhou ZG; Yan L; Tian HM; Luo ZJ; Yang LY; Liu J; Weng JP
Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):9-13. PubMed ID: 20356473
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study).
Xu W; Bi Y; Sun Z; Li J; Guo L; Yang T; Wu G; Shi L; Feng Z; Qiu L; Li Q; Guo X; Luo Z; Lu J; Shan Z; Yang W; Ji Q; Yan L; Li H; Yu X; Li S; Zhou Z; Lv X; Liang Z; Lin S; Zeng L; Yan J; Ji L; Weng J
J Intern Med; 2015 Jan; 277(1):137-50. PubMed ID: 25039675
[TBL] [Abstract][Full Text] [Related]
15. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.
Ryan EA; Imes S; Wallace C
Diabetes Care; 2004 May; 27(5):1028-32. PubMed ID: 15111515
[TBL] [Abstract][Full Text] [Related]
16. Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes.
Zheng HL; Xing Y; Li F; Ding W; Ye SD
Medicine (Baltimore); 2020 Apr; 99(14):e19685. PubMed ID: 32243407
[TBL] [Abstract][Full Text] [Related]
17. The intriguing effects of time to glycemic goal in newly diagnosed type 2 diabetes after short-term intensive insulin therapy.
Cheng L; Xu M; Lin X; Tang J; Qi Y; Wan Y; Pan X; Chen X; Ren M; Yan L
Endocr J; 2016 Aug; 63(8):739-46. PubMed ID: 27334121
[TBL] [Abstract][Full Text] [Related]
18. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
19. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
[TBL] [Abstract][Full Text] [Related]
20. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
